MedPageToday -- MILAN -- Fentanyl nasal spray controlled more than 90% of episodes of breakthrough pain in cancer patients -- without the need for rescue medication -- according to data from three phase III clinical trials.
MedPageToday -- MILAN -- Fentanyl nasal spray controlled more than 90% of episodes of breakthrough pain in cancer patients -- without the need for rescue medication -- according to data from three phase III clinical trials.